Literature DB >> 25683779

An optogenetic upgrade for the Tet-OFF system.

Konrad Müller1, Matias D Zurbriggen1,2, Wilfried Weber3,4.   

Abstract

The rapid development of mammalian optogenetics has produced an expanding number of gene switches that can be controlled with the unprecedented spatiotemporal resolution of light. However, in the "pre-optogenetic" era many networks, cell lines and transgenic organisms have been engineered that rely on chemically-inducible transgene expression systems but would benefit from the advantages of the traceless inducer light. To open the possibility for the effortless upgrade of such systems from chemical inducers to light, we capitalized on the specific Med25VBD inhibitor of the VP16/VP64 transactivation domain. In a first step, we demonstrated the efficiency and selectivity of Med25VBD in the inhibition of VP16/VP64-based transgene expression systems. Then, we fused the inhibitor to the blue light-responsive B-LID degron and optimized the performance of this construct with regard to the number of Med25VBD repeats. This approach resulted in an optogenetic upgrade of the popular Tet-OFF (TetR-VP64, tetO7 -PhCMVmin ) system that allows tunable, blue light-inducible transgene expression in HEK-293T cells.
© 2015 Wiley Periodicals, Inc.

Entities:  

Keywords:  TET system; gene switch; inducible expression; optogenetics

Mesh:

Year:  2015        PMID: 25683779     DOI: 10.1002/bit.25562

Source DB:  PubMed          Journal:  Biotechnol Bioeng        ISSN: 0006-3592            Impact factor:   4.530


  4 in total

Review 1.  Blue-Light Receptors for Optogenetics.

Authors:  Aba Losi; Kevin H Gardner; Andreas Möglich
Journal:  Chem Rev       Date:  2018-07-09       Impact factor: 60.622

2.  Noise-reducing optogenetic negative-feedback gene circuits in human cells.

Authors:  Michael Tyler Guinn; Gábor Balázsi
Journal:  Nucleic Acids Res       Date:  2019-08-22       Impact factor: 16.971

Review 3.  Gene-circuit therapy on the horizon: synthetic biology tools for engineered therapeutics.

Authors:  Rafał Krzysztoń; Yiming Wan; Julia Petreczky; Gábor Balázsi
Journal:  Acta Biochim Pol       Date:  2021-08-30       Impact factor: 2.149

Review 4.  Optogenetic regulation of transcription.

Authors:  Oksana Polesskaya; Ancha Baranova; Sarah Bui; Nikolai Kondratev; Evgeniya Kananykhina; Olga Nazarenko; Tatyana Shapiro; Frances Barg Nardia; Vladimir Kornienko; Vikas Chandhoke; Istvan Stadler; Raymond Lanzafame; Max Myakishev-Rempel
Journal:  BMC Neurosci       Date:  2018-04-19       Impact factor: 3.288

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.